MUREX DIAGNOSTICS CORP has a total of 12 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United Kingdom, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CETUS ONCOLOGY CORP, T CELL SCIENCES INC and UNIV HELSINKI LICENSING.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | United States | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Tedder Richard Seton | 4 |
#2 | Ferns Ruth Bridget | 4 |
#3 | Ijaz Samreen | 4 |
#4 | Duncan Richard Julian Stuart | 2 |
#5 | Tedder Richard Seaton | 1 |
#6 | Marshall David L | 1 |
#7 | Ferns Ruth | 1 |
#8 | Samreenljaz | 1 |
Publication | Filing date | Title |
---|---|---|
GB9801510D0 | Improvements in or relating to monitoring | |
GB9801509D0 | Improvements in or relating to monitoring | |
GB9722944D0 | Hepatitis B virus monoclonal antibodies | |
GB9722943D0 | Hepatitis B virus monoclonal antibodies | |
CA2211322A1 | Improvements to immunoassays | |
US5501949A | Particle bound binding component immunoassay |